HealthBeacon plc (HBCNF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to HealthBeacon plc (HBCNF) stock?
HealthBeacon plc (HBCNF) no longer trades on public markets. The figures below are historical and are not a current quote.
Market cap $8.44M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
HealthBeacon plc (HBCNF). HealthBeacon plc develops and commercializes digital therapeutic solutions for at-home injectable medication management. The company's system aims to improve patient adherence and outcomes through technology and data analytics. Market cap: $8.44M, Sector: Healthcare.
Last analyzed: Mar 18, 2026Analyst Coverage for HBCNF: HBCNF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HBCNF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
HBCNF: this read rests on a single discipline (Munger composite) — the other council disciplines have no scored data yet.
How is this calculated? →HealthBeacon plc (HBCNF) Healthcare & Pipeline Overview
HealthBeacon plc offers a digital therapeutics platform for managing injectable medications at home, leveraging technology to improve patient adherence and outcomes. The company operates in Europe, the United States, and Ireland, providing medication management, sharps disposal, and AI-driven data analytics within the healthcare information services sector.
What Is the Investment Thesis for HBCNF?
HealthBeacon plc presents a notable research candidate within the growing digital therapeutics market. The company's focus on improving medication adherence for injectable medications addresses a significant unmet need. Key value drivers include expansion into new geographic markets and partnerships with pharmaceutical companies and healthcare providers. The company's negative P/E ratio of -0.55 and a negative profit margin of -588.6% indicate that the company is not currently profitable. The company's low gross margin of 6.0% suggests challenges in achieving profitability. Upcoming catalysts include potential regulatory approvals and new product launches. The company's beta of -0.29 suggests lower volatility than the market.
Based on FMP financials and quantitative analysis
HBCNF Key Highlights
HealthBeacon plc operates in the digital therapeutics market, focusing on medication adherence for injectable medications.
- The company's injection care management system includes medication reminders, sharps disposal, and data analytics.
- HealthBeacon's solutions are available in Europe, the United States, and Ireland.
- The company's market capitalization is approximately $0.01 billion.
- HealthBeacon's gross margin is 6.0%.
Who Are HBCNF's Competitors?
HBCNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CDXFF Cloud DX Inc. | $0.09 | +12.50% | $9.75M | — |
| CRBKF Carebook Technologies Inc. | $0.03 | 0.00% | $6.84M | — |
| DOCRF CloudMD Software & Services Inc. | $0.02 | -19.29% | $6.25M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.48 | -1.98% | $8.82M | — |
| MGRX Mangoceuticals, Inc. | $0.39 | +1.51% | $6.63M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| SCNX Scienture Holdings, Inc. | $0.35 | -2.69% | $14.1M | — |
| BEAT HeartBeam, Inc. | $0.40 | -2.14% | $22.3M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HBCNF's Key Strengths?
Proprietary technology for medication adherence.
- Focus on injectable medications, a growing market.
- Partnerships with pharmaceutical companies.
- AI-driven data analytics for personalized interventions.
What Are HBCNF's Weaknesses?
Limited financial resources.
- Small market capitalization.
- Negative profitability.
- Reliance on partnerships for growth.
What Could Drive HBCNF Stock Higher?
Potential regulatory approvals for new products and services.
- Expansion into new geographic markets.
- Partnerships with pharmaceutical companies to integrate its solutions into their drug delivery programs.
- Development of new products and services to address other aspects of medication management.
- Integration with electronic health records (EHRs) to provide healthcare providers with a more complete view of their patients' medication adherence.
What Are the Key Risks for HBCNF?
Negative return on equity (-56.5%) — the business is not currently generating profit on shareholder capital.
- Competition from established healthcare companies.
- Regulatory hurdles for digital therapeutics.
- Data privacy and security concerns.
- Reimbursement challenges for digital health solutions.
- Limited financial resources may hinder growth initiatives.
What Are the Growth Opportunities for HBCNF?
- Expansion into new geographic markets: HealthBeacon has the opportunity to expand its presence in Europe and the United States, as well as enter new markets in Asia and Latin America. The global market for digital therapeutics is projected to reach $9.6 billion by 2027, providing a significant growth opportunity for the company. Timeline: Ongoing.
- Partnerships with pharmaceutical companies: HealthBeacon can partner with pharmaceutical companies to integrate its medication adherence solutions into their drug delivery programs. This can help pharmaceutical companies improve patient outcomes and increase sales. The pharmaceutical industry spends billions of dollars annually on patient support programs, creating a potential revenue stream for HealthBeacon. Timeline: Ongoing.
- Development of new products and services: HealthBeacon can develop new products and services to address other aspects of medication management, such as medication reconciliation and drug interactions. The market for medication management solutions is growing rapidly, driven by the increasing complexity of medication regimens. Timeline: Ongoing.
- Integration with electronic health records (EHRs): HealthBeacon can integrate its medication adherence data with EHRs to provide healthcare providers with a more complete view of their patients' medication adherence. This can help healthcare providers make more informed treatment decisions. The adoption of EHRs is increasing rapidly, creating a growing demand for integrated medication adherence solutions. Timeline: Ongoing.
- Leveraging AI and machine learning: HealthBeacon can leverage AI and machine learning to personalize medication adherence interventions and predict which patients are at risk of non-adherence. This can help healthcare providers target their interventions more effectively. The use of AI and machine learning in healthcare is growing rapidly, creating new opportunities for innovation. Timeline: Ongoing.
What Are HBCNF's Competitive Advantages?
- Proprietary technology: HealthBeacon's injection care management system is protected by patents and trade secrets.
- Data analytics: HealthBeacon's AI-driven data analytics provide valuable insights into patient adherence.
- Partnerships: HealthBeacon has established partnerships with pharmaceutical companies and healthcare providers.
What Does HBCNF Do?
HealthBeacon plc, established in 2013 and headquartered in Dublin, Ireland, is a digital therapeutics company focused on improving medication adherence for patients managing injectable medications at home. The company's core product is an injection care management system that combines technology and services to support patients throughout their treatment journey. This system provides medication management reminders, safe sharps disposal devices, educational tools, and AI-driven data analytics to track adherence and persistence. HealthBeacon's solutions are available in Europe, the United States, and Ireland. The company sells and leases its medical adherence technology devices and injection care management systems to healthcare providers and patients directly. By addressing the challenges of medication adherence, HealthBeacon aims to improve patient outcomes and reduce healthcare costs associated with non-adherence.
What Products and Services Does HBCNF Offer?
- Develops digital therapeutic solutions for managing injectable medications at home.
- Provides medication management reminders to patients.
- Offers safe and sustainable sharps disposal devices.
- Provides educational tools to patients.
- Utilizes AI-driven data analytics to track medication adherence.
- Sells and leases medical adherence technology devices.
- Offers injection care management systems.
How Does HBCNF Make Money?
- Sells and leases medical adherence technology devices to healthcare providers and patients.
- Generates revenue from subscriptions to its injection care management system.
- Partners with pharmaceutical companies to integrate its solutions into their drug delivery programs.
What Industry Does HBCNF Operate In?
The healthcare information services industry is experiencing rapid growth, driven by the increasing adoption of digital health solutions and the need for improved patient outcomes. HealthBeacon plc operates in this dynamic landscape, competing with companies offering medication adherence solutions and remote patient monitoring technologies. Competitors include BNOEF (Biofrontera Inc), CDXFF (CareDx Inc), CRBKF (Cornerstone Bank), DOCRF (Doximity Inc), and FLWPF (Welltower Inc). HealthBeacon's focus on injectable medications differentiates it from some competitors.
Who Are HBCNF's Key Customers?
- Patients who require injectable medications for chronic conditions.
- Healthcare providers who prescribe injectable medications.
- Pharmaceutical companies that manufacture injectable medications.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 44 |
| 2026-08-24 | 44 |
| 2026-08-25 | 44 |
| 2026-08-26 | 44 |
What changed?
The score has stayed at 44.
Over the same 3 days the stock moved +0.0%.
Key Financial Metrics
Return on equity for HealthBeacon plc stands at -56.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -53.1%, showing how much profit it generates from its asset base. A current ratio of 2.54 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -183.0%, the inverse of the P/E and a quick read on earnings relative to price.
HBCNF Valuation & Market Position
With a $8.44M market cap, HealthBeacon plc sits in the micro-cap segment of the market.
Company Profile
HealthBeacon plc operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Dublin, IE. The company is led by CEO Kieran Daly. HBCNF has traded publicly since 2022.
HBCNF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary technology for medication adherence.
- Focus on injectable medications, a growing market.
- Partnerships with pharmaceutical companies.
- AI-driven data analytics for personalized interventions.
Bear Case
- Limited financial resources.
- Small market capitalization.
- Negative profitability.
- Reliance on partnerships for growth.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HBCNF Latest News
No recent news available for HBCNF.
Leadership: Kieran Daly
CEO
Kieran Daly is the Chief Executive Officer of HealthBeacon plc. His background includes experience in the healthcare and technology sectors. He has held leadership positions in various companies, focusing on commercial strategy and business development. Daly's expertise lies in driving growth and innovation in the healthcare industry. He is responsible for leading HealthBeacon's strategic direction and execution.
Track Record: Under Kieran Daly's leadership, HealthBeacon plc has focused on expanding its market presence in Europe and the United States. He has overseen the development and launch of new products and services, including the integration of AI-driven data analytics into the company's injection care management system. Daly has also been instrumental in forging partnerships with pharmaceutical companies and healthcare providers.
HBCNF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that HealthBeacon plc may not meet the minimum financial or disclosure requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier may have limited financial information available to investors, and trading activity may be sporadic. Investing in companies on the OTC Other tier carries a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure: The lack of comprehensive financial information increases investment risk.
- Low liquidity: Difficulty in buying or selling shares can lead to significant price fluctuations.
- Higher price volatility: The combination of low liquidity and limited information can result in increased price volatility.
- Potential for fraud or manipulation: The OTC market is subject to less regulatory oversight than major exchanges, increasing the risk of fraudulent or manipulative activities.
- Going concern risk: Companies on the OTC Other tier may face financial difficulties and have a higher risk of going out of business.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the company's capital structure and any outstanding debt.
- Check for any regulatory filings or legal proceedings.
- Consult with a qualified financial advisor.
- Company is registered and incorporated in Ireland.
- HealthBeacon has partnerships with established pharmaceutical companies.
- The company has a functional website and actively promotes its products and services.
- HealthBeacon's products address a clear need in the healthcare market.
- Company has been in operation since 2013.
HealthBeacon plc Healthcare Stock: Key Questions Answered
What happened to HealthBeacon plc (HBCNF) stock?
HealthBeacon plc (HBCNF) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy HBCNF shares?
No. HBCNF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for HBCNF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HBCNF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to HealthBeacon plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does HealthBeacon plc do?
HealthBeacon plc is a digital therapeutics company specializing in medication adherence solutions for patients using injectable medications at home. The company's core offering is an injection care management system that combines technology and services to improve patient outcomes.
What do analysts say about HBCNF stock?
As of 2026-03-18, there is no readily available analyst consensus on HBCNF stock due to its OTC listing and limited coverage. Key valuation metrics such as P/E ratio (-0.55) and profit margin (-588.6%) suggest the company is not currently profitable.
What are the main risks for HBCNF?
The main risks for HealthBeacon plc include competition from established healthcare companies, regulatory hurdles for digital therapeutics, data privacy and security concerns, and reimbursement challenges for digital health solutions.
How does HealthBeacon plc manage patent expiration risks?
HealthBeacon plc mitigates patent expiration risks by continuously innovating and developing new features and products for its injection care management system.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than major exchange data.